我们的估值模...查看全文
BBAE必贝观察猫2019-09-30 19:56
BBAE 9月30日 盘前播报
必贝综合讯——
【指数方面】
道琼斯指数期货 +0.29%
纳斯达克指数期货 +0.48%
标普指数期货 +0.29%
【涨跌情况】
涨幅方面:
Dova制药(DOVA)+38.68%
中汽系统(CAAS)+19.4%
Calithera生物科学(CALA)+10.77%
Mitek系统(M...查看全文
源之谷港美股2019-06-29 03:42
文/文白
@今日话题@江涛 @雪盈证券 Wechat:yuanzhigu
下面统计今日数据
美股部分:
道琼斯指数(DJIA) 26,526.58,-0.04%, 2.46亿美元成交量
纳斯达克综合指数(NASDAQ) 7,967.76, +0.73%,18.9亿美元成交量
标普500指数(S&P 500) 2,924.92,0.38%, 17.3亿美元成交...查看全文
不予置评2019-06-27 23:24
今晚差点被家里的网给坑了,das这几天不知道为啥行情经常中途断线。后面实在不行就开了手机WiFi,不然还真是要命。
选股方面,由于网络原因,中间几乎有半个小时是在不停的重连。所以也没特别好的操作,另外今晚选的股票依旧没有符合自己的形态走得出来,大盘太闷了,似乎大家都在观望中。
查看全文
淘沙见金2019-06-27 22:59
$Dova制药(DOVA)$ sNDA批准,ITP这个症状下半年可以开卖。诺华$诺华制药(NVS)$ +安进$安进(AMGN)$ 在这个症状上一年卖了快2B。不知道DOVA/Salix能不能分到一口汤?个人感觉DOVA现在市值是低估的,而且药物有一定的优势,不过小药厂做销售嘛,粉身碎骨的例子太多了。查看全文
琳子的日复一日2018-05-22 09:58
一晚上三起sell on news惨案,美股市场你还能有点新意不? $Dova Pharmaceuticals, Inc.(DOVA)$ Dova Pharmaceuticals宣布美国FDA批准其子公司AkaRx的新药Doptelet(avatrombopag)片剂用于治疗计划接受医疗或牙科手术的慢性肝病(CLD)成人患者的低血小板计数(血小板减少症)。值得一提的是,这...查看全文
usbiostock2018-05-22 09:57
$Dova Pharmaceuticals, Inc.(DOVA)$ FDA批准Doptelet (avatrombopag)用于治疗成人慢性肝病患者伴发的血小板减少症。查看全文
不积跬步无以至2018-05-22 08:56
$Dova Pharmaceuticals, Inc.(DOVA)$ Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) today announced the U.S. Food and Drug Administration (FDA) has completed their Priority Review and approved DOPTELET® (avatrombopag) for the treatment of thrombocytopenia in adult patients with chro...查看全文
$Dova Pharmaceuticals, Inc.(DOVA)$ 424B4 - Prospectus [Rule 424(b)(4)] Filed: 2018-02-23 AccNo: 0001047469-18-001024 Size: 580 KB 网页链接
$Dova Pharmaceuticals, Inc.(DOVA)$ EFFECT - Notice of Effectiveness Filed: 2018-02-22 AccNo: 9999999995-18-000483 Size: 1 KB 网页链接
$Dova Pharmaceuticals, Inc.(DOVA)$ EFFECT - Notice of Effectiveness Filed: 2018-02-22 AccNo: 9999999995-18-000483 Size: 1 KB 网页链接
$Dova Pharmaceuticals, Inc.(DOVA)$ S-1 - General form for registration of securities under the Securities Act of 1933 Filed: 2018-02-20 AccNo: 0001047469-18-000895 Size: 959 KB 网页链接
$Dova Pharmaceuticals, Inc.(DOVA)$ DRS [Cover] - Draft Registration Statement Filed: 2018-01-26 AccNo: 0000912057-18-000044 Size: 2 MB 网页链接
$Dova Pharmaceuticals, Inc.(DOVA)$ S-1 - General form for registration of securities under the Securities Act of 1933 Filed: 2018-02-20 AccNo: 0001047469-18-000895 Size: 959 KB 网页链接
$Dova Pharmaceuticals, Inc.(DOVA)$ DRS [Cover] - Draft Registration Statement Filed: 2018-01-26 AccNo: 0000912057-18-000044 Size: 2 MB 网页链接
$Dova Pharmaceuticals, Inc.(DOVA)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-02-16 AccNo: 0001104659-18-010386 Size: 5 MB 网页链接
$Dova Pharmaceuticals, Inc.(DOVA)$ 8-K - Current report Filed: 2018-02-15 AccNo: 0001104659-18-010053 Size: 102 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Dova Pharmaceuticals, Inc.(DOVA)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-14 AccNo: 0001193125-18-045186 Size: 58 KB 网页链接